GOLDMAN SACHS GROUP INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$318,000600,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 1,500,000$1,161,0000.55%
OAKTREE CAPITAL MANAGEMENT LP 9,700,000$7,617,0000.12%
LAZARD ASSET MANAGEMENT LLC 10,500,000$8,281,0000.02%
Citadel Advisors 17,350,000$13,603,0000.01%
UBS ASSET MANAGEMENT AMERICAS LLC 15,800,000$12,250,372,0000.01%
AMERIPRISE FINANCIAL INC 15,900,000$12,303,0000.01%
CREDIT SUISSE AG/ 4,005,000$3,099,0000.00%
DEUTSCHE BANK AG\ 485,000$375,0000.00%
View complete list of PTC THERAPEUTICS INC shareholders